.
MergerLinks Header Logo

Announced

Gryphon Investors to acquire Metagenics from Alticor.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Domestic

health supplements

Private

Single Bidder

Specialty Retailers

Friendly

Private Equity

United States

Majority

Pending

Synopsis

Edit

Gryphon Investors, a private equity firm, agreed to acquire Metagenics, a nutritional supplement company, from Alticor, an American conglomerate. Financial terms were not disclosed. "Metagenics has a unique position as a leader among nutrition brands recommended by healthcare practitioners across its three core geographic markets. We are excited to invest behind the Metagenics mission, including helping their healthcare practitioner partners to support the health of their patients around the world," Mike Ferry, Gryphon Operating Partner.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US